Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06240299 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)

Study acronym: NECTAR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: May 31, 2025 to Jan 29, 2027v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2024 to Jun 24, 2024
    • Primary completion date: Mar 31, 2025 to May 31, 2025
    • Site details revised
    v3
  3. Secondary endpoints: details revised at 5 of 9 entries
    • Eligibility criteria expanded, about 2 words
    • Study description shortened, about 3 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Rheumatoid arthritis is an autoimmune condition, causing inflammation and pain. Yet pain may persist even when inflammation has been treated. This residual pain, called nociplastic pain, has symptoms of a chronic pain condition called fibromyalgia. There are few effective therapies to address this residual pain. Published literature shows that fibromyalgia can be treated by neurofeedback, a noninvasive method that is based on the voluntary modulation of cortical activity. In this pilot study, the investigators want to test the effect of neurofeedback on the fibromyalgia component of pain in rheumatoid arthritis, and also to investigate its effects on related symptoms such as fatigue and sleep disturbance.
Trial Details
NCT Number NCT06240299
Lead Sponsor NHS Greater Glasgow and Clyde
Collaborators: University of Glasgow
Conditions
(from sponsor)		 Rheumatoid Arthritis, Chronic Widespread Pain
Related terms Arthritis, Rheumatoid, Chronic Pain
Enrollment 16 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov